Insulin-like growth factor binding protein-3, in association with IGF-1 receptor, can predict prognosis in squamous cell carcinoma of the head and neck

Oral Oncology

Volumn 47, Issue 8, 2011, Pages 714-719

  Sun, Jong Mu ^a   Jun, Hyun Jung ^a   Ko, Young Hyeh ^a   Park, Yeon Hee ^a   Ahn, Yong Chan ^a   Son, Young Ik ^a   Baek, Jeong Hwan ^a   Park, Keunchil ^a   Ahn, Myung Ju ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

IGF 1R; IGFBP 3; Immunohistochemistry; Prognosis; Squamous cell carcinoma of the head and neck

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, IGF TYPE 1; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 79960700882     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.06.007     Document Type: Article

References (28)

1. D. Chin, G.M. Boyle, S. Porceddu, D.R. Theile, P.G. Parsons, and W.B. Coman Head and neck cancer: past, present and future Expert Rev Anticancer Ther 6 2006 1111 1118 (Pubitemid 44203388)
2. J.B. Vermorken, R. Mesia, F. Rivera, E. Remenar, A. Kawecki, and S. Rottey Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 2008 1116 1127
3. M.H. Chang, J. Lee, J. Han, Y.H. Park, J.S. Ahn, and K. Park Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer APMIS 117 2009 861 869
4. R. Kaaks, P. Toniolo, A. Akhmedkhanov, A. Lukanova, C. Biessy, and H. Dechaud Serum c-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women J Natl Cancer Inst 92 2000 1592 1600
5. K. Satyamoorthy, G. Li, B. Vaidya, D. Patel, and M. Herlyn Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and β-catenin pathways Cancer Res 61 2001 7318 7324 (Pubitemid 32946531)
6. H. Yu, M.R. Spitz, J. Mistry, J. Gu, W.K. Hong, and X. Wu Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis J Natl Cancer Inst 91 1999 151 156 (Pubitemid 29042692)
7. R. Dziadziuszko, D.T. Merrick, S.E. Witta, A.D. Mendoza, B. Szostakiewicz, and A. Szymanowska Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression J Clin Oncol 28 2010 2174 2180
8. C.J. Barnes, K. Ohshiro, S.K. Rayala, A.K. El-Naggar, and R. Kumar Insulin-like growth factor receptor as a therapeutic target in head and neck cancer Clin Cancer Res 13 2007 4291 4299 (Pubitemid 47105993)
9. A.M. Vincent, and E.L. Feldman Control of cell survival by IGF signaling pathways Growth Horm IGF Res 12 2002 193 197 (Pubitemid 35230190)
10. J. hlén, J. Wejde, O. Brosjö, A. von Rosen, W.-H. Weng, and L. Girnita Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma Clin Cancer Res 11 2005 206 216 (Pubitemid 40075797)
11. F. Cappuzzo, G. Tallini, G. Finocchiaro, R.S. Wilson, C. Ligorio, and L. Giordano Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients Ann Oncol 21 2010 562 567
12. C.Y. Lee, J.H. Jeon, H.J. Kim, D.H. Shin, T.W. Roh, and C.M. Ahn Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis Korean J Intern Med 23 2008 116 120
13. D.T. Merrick, R. Dziadziuszko, B. Szostakiewicz, A. Szymanowska, W. Rzyman, and E. Jassem High insulin-like growth factor 1 receptor (IGF1R) expression is associated with poor survival in surgically treated non-small cell lung cancer (NSCLC) patients (pts) J Clin Oncol (Meeting Abstracts) 25 2007 7550
14. N.K. Taunk, S. Goyal, M.S. Moran, Q. Yang, R. Parikh, and B.G. Haffty Prognostic significance of IGF-1R expression in patients treated with breast-conserving surgery and radiation therapy Radiother Oncol 96 2010 204 208
15. S.M. Firth, and R.C. Baxter Cellular actions of the insulin-like growth factor binding proteins Endocr Rev 23 2002 824 854 (Pubitemid 35454590)
16. C. Conover Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism Endocrinology 130 1992 3191 3199
17. P.L. Torng, Y.C. Lee, C.Y. Huang, J.H. Ye, Y.S. Lin, and Y.W. Chu Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma Oncogene 27 2008 2137 2147
18. R.L. Rocha, S.G. Hilsenbeck, J.G. Jackson, C.L. VanDenBerg, C. Weng, and A.V. Lee Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival Clin Cancer Res 3 1997 103 109 (Pubitemid 27079451)
19. Y.S. Chang, K. Gong, S. Sun, D. Liu, A.K. El-Naggar, and F.R. Khuri Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer Clin Cancer Res 8 2002 3796 3802 (Pubitemid 35424772)
20. H. Yu, M.A. Levesque, M.J. Khosravi, A. Papanastasiou-Diamandi, G.M. Clark, and E.P. Diamandis Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer Br J Cancer 74 1996 1242 1247 (Pubitemid 26360113)
21. V.A. Papadimitrakopoulou, E.N. Brown, D.D. Liu, A.K. El-Naggar, J. Jack Lee, and W.K. Hong The prognostic role of loss of insulin-like growth factor-binding protein-3 expression in head and neck carcinogenesis Cancer Lett 239 2006 136 143 (Pubitemid 43946585)
22. C.-H. Tsai, S.-F. Yang, Y.-J. Chen, M.-Y. Chou, and Y.-C. Chang The upregulation of insulin-like growth factor-1 in oral submucous fibrosis Oral Oncol 41 2005 940 946 (Pubitemid 41265954)
23. X. Wu, H. Zhao, K.A. Do, M.M. Johnson, Q. Dong, and W.K. Hong Serum levels of insulin growth factor (IGF-I) and IGF-binding protein predict risk of second primary tumors in patients with head and neck cancer Clin Cancer Res 10 2004 3988 3995 (Pubitemid 38812472)
24. Y. Xi, G. Nakajima, T. Hamil, O. Fodstad, A. Riker, and J. Ju Association of insulin-like growth factor binding protein-3 expression with melanoma progression Mol Cancer Ther 5 2006 3078 3084 (Pubitemid 46092049)
25. G.F. Øy, A. Slipicevic, B. Davidson, R.M. Solberg Faye, G. Mælandsmo, and V.A. Flørenes Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma Int J Cancer 126 2010 350 361
26. D.D. Karp, L.G. Paz-Ares, S. Novello, P. Haluska, L. Garland, and F. Cardenal Phase II study of the anti-insulin-like growth factor type 1 receptor antibody cp-751, 871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer J Clin Oncol 27 2009 2516 2522
27. National Institutes of Health. Clinical trial registry. A study of CP-751,871 in patients with recurrent squamous head and neck carcinoma [NCT00872404]; 2011. Available from: http://www.clinicaltrials.gov [accessed 07.04.2011].
28. National Institutes of Health. Clinical trials registry. Study of IMC-A12, alone or in combination with cetuximab, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck [NCT00617734]; 2011. Available from: http://www.clinicaltrials.gov [accessed 07.04.2011].